Making pharmaceutical research and regulation work for women

KEY MESSAGES

•  Despite increasing evidence of the influence of sex and gender on pharmaceutical outcomes, and some positive country specific regulatory shifts, notable gaps exist in the integration of sex and gender in pharmaceutical research and regulations

•  Stronger governance and oversight from regulatory agencies, and commitment by the scientific entrepreneur community, are needed to drive more sex and gender responsive pharmaceutical research, reporting, regulation, and commercialisation

•  More women committed to gender equality in leadership and decision making roles in pharmaceutical research and regulation is critical